BILM Position Statement: The ARPA-H PROSPR Programme and Trials Targeting Ageing
British Institute for Longevity Medicine (BILM) | bilm.org.uk 1. Summary The British Institute for Longevity Medicine warmly welcomes the PROactive Solutions for Prolonging Resilience (PROSPR) programme from the US Advanced Research Projects Agency for Health (ARPA-H). A major public funder is paying for large, placebo-controlled trials that ask whether existing or new drugs can preserve […]